Cargando…
Biomarkers in Bladder Cancer Surveillance
Aim: This is a narrative review with an aim to summarise and describe urinary biomarkers in the surveillance of non-muscle-invasive bladder cancer (NMIBC). It provides a summary of FDA-approved protein biomarkers along with emerging ones which utilise genetic, epigenetic and exosomal markers. We dis...
Autores principales: | Sugeeta, Sukumar S., Sharma, Anand, Ng, Kenrick, Nayak, Arvind, Vasdev, Nikhil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506024/ https://www.ncbi.nlm.nih.gov/pubmed/34651010 http://dx.doi.org/10.3389/fsurg.2021.735868 |
Ejemplares similares
-
Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era
por: Ng, Kenrick, et al.
Publicado: (2020) -
Single tertiary cancer center experience on the management of pT3b prostate cancer after robotic-assisted laparoscopic prostatectomy
por: Nayak, Arvind, et al.
Publicado: (2022) -
Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer
por: Chhaya, Saachi, et al.
Publicado: (2023) -
Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer—A Pilot Study
por: Chai, C. A., et al.
Publicado: (2021) -
Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
por: Zhao, Hongda, et al.
Publicado: (2021)